Page last updated: 2024-09-04

drospirenone and ethinyl estradiol combination and ritonavir

drospirenone and ethinyl estradiol combination has been researched along with ritonavir in 1 studies

Compound Research Comparison

Studies
(drospirenone and ethinyl estradiol combination)
Trials
(drospirenone and ethinyl estradiol combination)
Recent Studies (post-2010)
(drospirenone and ethinyl estradiol combination)
Studies
(ritonavir)
Trials
(ritonavir)
Recent Studies (post-2010) (ritonavir)
130511025,4191,2912,772

Protein Interaction Comparison

ProteinTaxonomydrospirenone and ethinyl estradiol combination (IC50)ritonavir (IC50)
Solute carrier organic anion transporter family member 2B1 Homo sapiens (human)6.1
Bile salt export pumpHomo sapiens (human)2.085
ATP-dependent translocase ABCB1Homo sapiens (human)2.65
Cytochrome P450 3A4Homo sapiens (human)0.1623
Cytochrome P450 2D6Homo sapiens (human)2.3
Cytochrome P450 2C9 Homo sapiens (human)2.458
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)0.067
Substance-K receptorHomo sapiens (human)2.622
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)2.35
Thromboxane-A synthase Homo sapiens (human)0.076
Multidrug and toxin extrusion protein 2Homo sapiens (human)4.4
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.1933
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.4
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)2
Protease Human immunodeficiency virus 14.9253

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Serres, M; Gould, E; Johnson, M; Kim, J; Lou, Y; Mayers, D; Pietropaolo, K; Piscitelli, S; White, S; Zhou, XJ1

Trials

1 trial(s) available for drospirenone and ethinyl estradiol combination and ritonavir

ArticleYear
Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.
    British journal of clinical pharmacology, 2012, Volume: 74, Issue:2

    Topics: Adenine; Androstenes; Anti-HIV Agents; Atazanavir Sulfate; Atorvastatin; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Interactions; Emtricitabine; Ethinyl Estradiol; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Least-Squares Analysis; Linear Models; Lopinavir; Male; Oligopeptides; Organophosphonates; Patient Safety; Phosphinic Acids; Pyridines; Pyrimidines; Pyrroles; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Risk Assessment; Ritonavir; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Tenofovir

2012